Global Continuous Glucose Monitoring Devices Market Analysis Report 2024-2030, Featuring Dexcom, Abbott, Medtronic, Ypsomed, Senseonics Holdings, A. Menarini Diagnostics and Signos
Global Continuous Glucose Monitoring Devices Market Analysis Report 2024-2030, Featuring Dexcom, Abbott, Medtronic, Ypsomed, Senseonics Holdings, A. Menarini Diagnostics and Signos
DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "Global Continuous Glucose Monitoring Devices Market Size, Share, & Trends Analysis Report by Component (Transmitters, Sensors, Receivers), End-use (Hospitals, Homecare), Connectivity, Region and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.
都柏林,2024年2月20日 /PRNewswire/ — “按組件(發射器、傳感器、接收器)、最終用途(醫院、家庭護理)、連接、地區和細分市場預測劃分的2024-2030年全球連續血糖監測設備市場規模、份額和趨勢分析報告” 已添加到 ResearchandMarkets.co 提供。
The global continuous glucose monitoring devices market is anticipated to reach USD 7.51 billion by 2030 and it is projected to grow at a CAGR of 7.19% from 2024 to 2030. Growing cases of diabetes and introduction of novel and advanced diabetes care and management devices are the major factors driving the market growth. Continuous glucose monitoring (CGM) devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep track of glucose levels over a designated period.
預計到2030年,全球連續血糖監測設備市場將達到75.1億美元,預計從2024年到2030年將以7.19%的複合年增長率增長。糖尿病病例的增加以及新型和先進的糖尿病護理和管理設備的引入是推動市場增長的主要因素。連續血糖監測(CGM)設備爲實時測量體內葡萄糖水平提供了一種有效的方法。這些設備記錄的數據通過無線網絡傳輸到接收器;這有助於跟蹤指定時間段內的血糖水平。
With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Apps such as Glucose buddy, Diabetes Connect, MySugar, and others are available under paid subscription. Further, the rise in the number of diabetes mellitus has contributed significantly toward the global market growth. The device allows real time biofeedback and behavioral change support, allowing effective management of diabetes by the patient.
隨着數字療法的出現,越來越多的連續血糖監測設備與應用程序和軟件相結合,以幫助糖尿病患者。Glucose buddy、Diabetes Connect、MySugar等應用程序可通過付費訂閱獲得。此外,糖尿病人數的增加爲全球市場的增長做出了重大貢獻。該設備允許實時生物反饋和行爲改變支持,從而使患者能夠有效地管理糖尿病。
Additionally, the government is spending a huge amount on diabetic care tools to closely monitor diabetes in patient. For instance, according to American Diabetes Association, the overall cost of diagnosed diabetes in the United States for the year 2022 is estimated to be USD 412.9 billion. This amount encompasses direct medical costs of USD 306.6 billion and indirect costs of USD 106.3 billion associated with diabetes.
Diabetes management demands intensive efforts to maintain normal glucose levels and reduce complications, decrease healthcare expenditures, & prevent premature death. This involves monitoring blood sugar levels, taking insulin, following a proper diet, and regular exercising. However, the current sensor technology used to monitor glucose levels only works with a "one-size-fits-all" approach, which does not cater to the special needs of subpopulations such as senior citizens, ethnic minorities, children, adolescents, and people with limited resources. To rectify this, future diabetes technology must be adaptable to diverse users. The ideal devices should be customizable, user-friendly, and affordable. These devices can also be combined with behavioral interventions to promote patient- & family-centered care and provide decision-support tools for clinicians. Although there have been significant advancements in CGM technology, its widespread use is still limited by biological, pharmacological, and socioeconomic factors. Aforementioned factors suggests continuous glucose monitoring devices market growth in the near future.
Continuous Glucose Monitoring Device Market Report Highlights
此外,政府正在花費大量資金購買糖尿病護理工具,以密切監測患者的糖尿病。例如,根據美國糖尿病協會的數據,2022年美國診斷出的糖尿病的總成本估計爲4129億美元。該金額包括3,066億美元的直接醫療費用和與糖尿病相關的1,063億美元的間接費用。
糖尿病管理需要付出大量努力,以維持正常的血糖水平,減少併發症,減少醫療開支,防止過早死亡。這包括監測血糖水平、服用胰島素、遵循適當的飲食和定期運動。但是,目前用於監測血糖水平的傳感器技術只能採用 “一刀切” 的方法,無法滿足老年人、少數民族、兒童、青少年和資源有限者等亞群的特殊需求。爲了糾正這種情況,未來的糖尿病技術必須能夠適應不同的用戶。理想的設備應該是可定製、用戶友好且價格合理的。這些設備還可以與行爲干預措施相結合,促進以患者和家庭爲中心的護理,併爲臨床醫生提供決策支持工具。儘管CGM技術取得了重大進步,但其廣泛使用仍然受到生物、藥理和社會經濟因素的限制。上述因素表明,血糖監測設備市場在不久的將來會持續增長。
連續血糖監測設備市場報告亮點
- Based on the component, the sensors segment led the market in 2023 with the largest revenue share of 40.66%, owing to technological advancements in the sensor technology such as development of smaller, more accurate, and longer-lasting sensors, which has made them more comfortable and convenient for users
- Based on the connectivity, the Bluetooth segments led the market with the largest revenue share of 59.6% in 2023. Bluetooth chip-enabled sensors are growing rapidly in the CGM market due to their ability to seamlessly transmit data to a connected device
- Based on the end-use, the homecare segment is expected to grow at a fastest CAGR of 7.73% and projected to maintain its dominance over the forecast period
- North America dominated the market with a revenue share in 2023, attributed to wide adoption of CGM devices along with the increasing prevalence of diabetes disorder in the region
- The Europe continuous glucose monitoring devices market holds the second largest market share in 2023 and expected to grow at a significant CAGR in the forecast period. The increasing awareness about the benefits of CGM devices, such as real-time monitoring of glucose levels, early detection of hypoglycemia and hyperglycemia, and reduction in HbA1c levels, is driving the demand for CGM devices in the region
- 基於該組件,傳感器細分市場在2023年以最大的收入份額領先市場,爲40.66%,這要歸因於傳感器技術的進步,例如開發了更小、更精確、更耐用的傳感器,這使用戶更舒適、更方便
- 根據連接性,藍牙細分市場在2023年以59.6%的最大收入份額領先市場。支持藍牙芯片的傳感器由於能夠無縫地將數據傳輸到連接的設備而在 CGM 市場中迅速增長
- 根據最終用途,家庭護理細分市場預計將以7.73%的最快複合年增長率增長,並預計將在預測期內保持其主導地位
- 北美在2023年以收入份額主導了市場,這要歸因於CGM設備的廣泛採用以及該地區糖尿病患病率的上升
- 歐洲連續血糖監測設備市場在2023年佔有第二大市場份額,預計將在預測期內以可觀的複合年增長率增長。人們對CGM設備益處的認識不斷提高,例如實時監測血糖水平、早期發現低血糖和高血糖以及降低HbA1c水平,推動了該地區對CGM設備的需求
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage
3.2. Continuous Glucose Monitoring Devices Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of diabetes
3.2.1.2. Rising geriatric population
3.2.1.3. Rising adoption of Continuous Glucose Monitoring (CGM) devices and technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of CGM devices and lack of reimbursement policies
3.3. Business Environmental Tools Analysis: Continuous Glucose Monitoring Devices Market
3.4. Pricing Analysis
Chapter 4. Continuous Glucose Monitoring Devices Market: Component Estimates & Trend Analysis
4.1. Continuous Glucose Monitoring Devices market, by Component: Key Takeaways
4.2. Continuous Glucose Monitoring Devices Market: Component Movement Analysis
4.3. Transmitters
4.4. Sensors
4.5. Receivers
Chapter 5. Continuous Glucose Monitoring Devices Market: Connectivity Estimates & Trend Analysis
5.1. Continuous Glucose Monitoring Devices market, by Connectivity: Key Takeaways
5.2. Continuous Glucose Monitoring Devices Market: Connectivity Movement Analysis
5.3. Bluetooth
5.4. 4G
Chapter 6. Continuous Glucose Monitoring Devices Market: End-use Estimates & Trend Analysis
6.1. Continuous Glucose Monitoring Devices Market, by End-use: Key Takeaways
6.2. Continuous Glucose Monitoring Devices Market: End-use Movement Analysis
6.3. Hospitals
6.4. Home Care Settings
6.5. Others
Chapter 7. Continuous Glucose Monitoring Devices Market: Regional Estimates & Trend Analysis
7.1. Continuous Glucose Monitoring Devices Market: Regional Movement Analysis, 2023 & 2030
7.2. North America
7.3. Europe
7.4. Asia-Pacific
7.5. Latin America
7.6. Middle East & Africa
Chapter 8. Competitive Landscape
8.1. Participants Overview
8.2. Company Categorization
8.3. Financial Performance
8.4. Company Profiles
涵蓋的關鍵主題:
第 1 章。方法和範圍
第 2 章。執行摘要
2.1。市場快照
2.2。分段快照
2.3。競爭見解快照
第三章。市場變量、趨勢和範圍
3.1。市場譜系
3.2。連續血糖監測設備市場-市場動態
3.2.1。市場驅動因素分析
3.2.1.1。糖尿病患病率上升
3.2.1.2。老年人口不斷增加
3.2.1.3。持續血糖監測(CGM)設備的採用率不斷提高,技術進步
3.2.2。市場限制分析
3.2.2.1。CGM 設備成本高昂且缺乏報銷政策
3.3。商業環境工具分析:連續血糖監測設備市場
3.4。定價分析
第四章。連續血糖監測設備市場:成分估計和趨勢分析
4.1。按組成部分劃分的連續血糖監測設備市場:關鍵要點
4.2。連續血糖監測設備市場:成分運動分析
4.3。發射機
4.4。傳感器
4.5。接收器
第 5 章。連續血糖監測設備市場:連接估計和趨勢分析
5.1。按連接劃分的連續血糖監測設備市場:關鍵要點
5.2。連續血糖監測設備市場:連接運動分析
5.3。藍牙
5.4. 4G
第 6 章連續血糖監測設備市場:最終用途估計和趨勢分析
6.1。按最終用途劃分的連續血糖監測設備市場:關鍵要點
6.2。連續血糖監測設備市場:最終用途運動分析
6.3。醫院
6.4。家庭護理設置
6.5。其他
第 7 章。連續血糖監測設備市場:區域估計和趨勢分析
7.1。連續血糖監測設備市場:2023年和2030年區域運動分析
7.2。北美
7.3。歐洲
7.4。亞太地區
7.5。拉丁美洲
7.6。中東和非洲
第八章。競爭格局
8.1。參與者概述
8.2。公司分類
8.3。財務業績
8.4。公司簡介
- Dexcom
- Abbott
- Medtronic
- Ypsomed
- Senseonics Holdings
- A. Menarini Diagnostics
- Signos
- Dexcom
- 雅培
- 美敦力
- Ypsomed
- Senseonics 控股公司
- A. 美納里尼診斷
- Signos
For more information about this report visit
有關此報告的更多信息,請訪問
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
關於 ResearchandMarkets
ResearchandMarkets.com是全球領先的國際市場研究報告和市場數據來源。我們爲您提供有關國際和地區市場、關鍵行業、頂級公司、新產品和最新趨勢的最新數據。
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
媒體聯繫人:
研究與市場
勞拉·伍德,高級經理
[電子郵件保護]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
如需了解歐洲安全局的辦公時間,請致電 +1-917-300-0470
如需美國/加拿大免費電話,請致電 +1-800-526-8630
如需了解格林尼治標準時間辦公時間,請致電 +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
美國傳真:646-607-1907
傳真(美國境外):+353-1-481-1716
Logo:
徽標:
SOURCE Research and Markets
來源:研究與市場
譯文內容由第三人軟體翻譯。